Nxera Pharma Co., Ltd. (TYO:4565)

Nxera Pharma Revenue

Nxera Pharma had revenue of 11.26B JPY in the quarter ending March 31, 2026, with 69.42% growth. This brings the company's revenue in the last twelve months to 34.23B, up 10.88% year-over-year. In the year 2025, Nxera Pharma had annual revenue of 29.62B with 2.71% growth.

• Revenue (ttm): 34.23B
• Revenue Growth: +10.88%
• P/S Ratio: 3.25
• Revenue / Employee: 89.60M
• Employees: 382
• Market Cap: 111.18B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	29.62B	780.00M	2.71%
Dec 31, 2024	28.84B	16.07B	125.87%
Dec 31, 2023	12.77B	-2.80B	-18.00%
Dec 31, 2022	15.57B	-2.14B	-12.10%
Dec 31, 2021	17.71B	8.87B	100.32%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 7, 2026

Data Sources Report a data error